Skip to main content
Ir a la página de inicio de la Comisión Europea (se abrirá en una nueva ventana)
español es
CORDIS - Resultados de investigaciones de la UE
CORDIS
Contenido archivado el 2024-05-07

Synthesis of divergent intermediates for the generation of analogues of spicamycin for the study and treatment of cancer and tuberculosis

Objetivo



Research objectives and content
The synthesis of divergent intermediates for the generation of spicamycin and analogues, which may be promising as potential cancer and tuberculosis therapeutics.
Training content (objective, benefit and expected impact)
This project provides an opportunity to do exciting chemistry, using new techniques and aspects of modern synthetic and bioorganic chemistry. Links with industry / industrial relevance (22)
The project will receive an important support from pharmaceutical c companies. We will work in collaboration with their biologists.

Ámbito científico (EuroSciVoc)

Programa(s)

Tema(s)

Convocatoria de propuestas

Datos no disponibles

Régimen de financiación

RGI - Research grants (individual fellowships)

Coordinador

THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD
Aportación de la UE
Sin datos
Dirección
South Parks Road
OX1 3QY OXFORD
Reino Unido
Coste total
Sin datos

Participantes (1)